Prelude Capital Management’s Pulmonx LUNG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-16,200
| Closed | -$103K | – | 1333 |
|
|
2024
Q2 | $103K | Buy |
16,200
+4,000
| +33% | +$25.4K | 0.01% | 1004 |
|
|
2024
Q1 | $113K | Sell |
12,200
-712
| -6% | -$6.6K | 0.01% | 1075 |
|
|
2023
Q4 | $165K | Buy |
+12,912
| New | +$165K | 0.01% | 854 |
|
|
2022
Q4 | – | Sell |
-21,704
| Closed | -$362K | – | 1349 |
|
|
2022
Q3 | $362K | Buy |
+21,704
| New | +$362K | 0.01% | 770 |
|
|
2022
Q1 | – | Sell |
-11,300
| Closed | -$362K | – | 1737 |
|
|
2021
Q4 | $362K | Buy |
11,300
+3,205
| +40% | +$103K | 0.01% | 944 |
|
|
2021
Q3 | $291K | Buy |
8,095
+104
| +1% | +$3.74K | 0.01% | 862 |
|
|
2021
Q2 | $353K | Buy |
+7,991
| New | +$353K | 0.01% | 910 |
|